Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 11,320 | 19,495 | 10,790 | 10,967 | 21,646 |
| Cost of Goods | 4,765 | 2,752 | 2,868 | 1,827 | 3,426 |
| Gross Profit | 6,555 | 16,743 | 7,922 | 9,140 | 18,220 |
| Operating Expenses | 11,025 | 14,656 | 11,372 | 12,207 | 13,953 |
| Operating Income | -3,705 | 2,839 | -2,582 | -2,240 | 4,693 |
| Other Income | -1,770 | -2,442 | -1,855 | -1,910 | -3,026 |
| Pre-tax Income | -5,475 | 397 | -4,437 | -4,150 | 1,667 |
| Net Income Continuous | -5,475 | 397 | -4,437 | -4,150 | 1,667 |
| Net Income | $-5,475 | $397 | $-4,437 | $-4,150 | $1,667 |
| EPS Basic Total Ops | -0.14 | -0.05 | -0.14 | -0.13 | 0.10 |
| EPS Basic Continuous Ops | -0.14 | -0.06 | -0.14 | -0.13 | 0.10 |
| EPS Diluted Total Ops | -0.14 | -0.05 | -0.14 | -0.13 | 0.10 |
| EPS Diluted Continuous Ops | -0.14 | -0.06 | -0.14 | -0.13 | 0.10 |
| EBITDA(a) | $-2,474 | $4,052 | $-1,398 | $-1,061 | $5,889 |